Comparison of minoxidil sulfotransferase activity between scalp hair, eyebrows, and eyelashes: Implication for minoxidil efficacy for off-label use. Nina Mehta, Andy Goren. J Cosmet Dermatol. 2024 Apr 4. Online ahead of print. ISSN: 1473-2130 eISSN: 1473-2165; https://doi.org/10.1111/jocd.16322.

Minoxidil sulfotransferase enzymatical activity in plants: A novel paradigm in increasing minoxidil response in androgenetic alopecia. Nina Mehta, Sam Huang, Rachita Dhura, Carlos Wambier, Daniel do Nascimento Fonesca, Sabrina Little, Andy Goren. J Cosmet Dermatol. 2023 Aug 28. Online ahead of print. PMID: 37638619 DOI: 10.1111/jocd.15980.

Rosacea Management: A Comprehensive Review. Sharma A, Kroumpouzos G, Kassir M, Galadari H, Goren A, Grabbe S, Goldust M. J Cosmet Dermatol. 2022 Feb 1. doi: 10.1111/jocd.14816. Epub ahead of print. PMID: 35104917.

Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial. Cadegiani FA, Zimerman RA, Fonseca DN, Correia MN, Muller MP, Bet DL, Slaviero MR, Zardo I, Benites PR, Barros RN, Paulain RW, Onety DC, Israel KCP, Gustavo Wambier C, Goren A. Cureus. 2021 Dec 25;13(12):e20691. doi: 10.7759/cureus.20691. PMID: 34976549; PMCID: PMC8712234.

Can sunlight affect COVID-19 outcomes? What is the available evidence? Khazdair MR, Goren A. Clin Exp Emerg Med. 2021 Sep;8(3):249-250. doi: 10.15441/ceem.21.045. Epub 2021 Sep 30. PMID: 34649415; PMCID: PMC8517466.

Time of onset and duration of post-COVID-19 acute telogen effluvium. Abrantes TF, Artounian KA, Falsey R, Simão JCL, Vañó-Galván S, Ferreira SB, Davis TL, Ridenour W, Goren A, Tosti A, Wambier CG. J Am Acad Dermatol. 2021 Oct;85(4):975-976. doi: 10.1016/j.jaad.2021.07.021. Epub 2021 Jul 21. PMID: 34302903; PMCID: PMC8294706.

New Coronavirus (SARS-CoV-2) Crossing Borders Beyond Cities, Nations, and Continents: Impact of International Travel. Arora P, Mrig S, Goldust Y, Kroumpouzos G, Karadağ AS, Rudnicka L, Galadari H, Szepietowski JC, Di Lernia V, Goren A, Kassir M, Goldust M. Balkan Med J. 2021 Jul;38(4):205-211. doi: 10.5152/balkanmedj.2021.21074. PMID: 34274909.

Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known outcomes in untreated patients. Cadegiani FA, Goren A, Wambier CG, McCoy J. New Microbes New Infect. 2021 Sep;43:100915. doi: 10.1016/j.nmni.2021.100915. Epub 2021 Jul 7. PMID: 34249367; PMCID: PMC8262389.

ARS-CoV-2 infection in patients with thyroid disease: a cross-sectional study. Nguyen C, Yale K, Ghigi A, Zheng K, Mesinkovska NA, Wambier CG, Cadegiani FA, Goren A. SAnn Thyroid. 2022 Mar;6:7. doi: 10.21037/aot-21-8. Epub 2021 Mar 30. PMID: 34151187; PMCID: PMC8211102.

SULT1A1 (Minoxidil Sulfotransferase) enzyme booster significantly improves response to topical minoxidil for hair regrowth. Dhurat R, Daruwalla S, Pai S, Kovacevic M, McCoy J, Shapiro J, Sinclair R, Vano-Galvan S, Goren A. J Cosmet Dermatol. 2022 Jan;21(1):343-346. doi: 10.1111/jocd.14299. Epub 2021 Jun 25. PMID: 34133836.

Novel cannabidiol aspartame combination treatment (JW-100) significantly reduces ISGA score in atopic dermatitis: Results from a randomized double-blinded placebo-controlled interventional study. Gao Y, Li Y, Tan Y, Liu W, Ouaddi S, McCoy J, Kovacevic M, Situm M, Stanimirovic A, Li M, Wambier C, Goren A, Zou Y. J Cosmet Dermatol. 2021 May 31. doi: 10.1111/jocd.14263. Epub ahead of print. PMID: 34056830.

Stay-At-Home Orders Are Associated With Emergence of Novel SARS-CoV-2 Variants. Zimerman RA, Cadegiani FA, Pereira E Costa RA, Goren A, Campello de Souza B.  Cureus. 2021 Mar 11;13(3):e13819. doi: 10.7759/cureus.13819. PMID: 33728228; PMCID: PMC7949745.

Androgens and women: COVID-19 outcomes in women with acne vulgaris, polycystic ovarian syndrome, and hirsutism. Yale K, Elsanadi R, Ghigi A, Zheng K, Goren A, Mesinkovska NA. Int J Dermatol. 2021 Jul;60(7):e267-e268. doi: 10.1111/ijd.15473. Epub 2021 Mar 2. PMID: 33650165; PMCID: PMC8014631.

Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical). Cadegiani FA, McCoy J, Gustavo Wambier C, Goren A. Cureus. 2021 Feb 1;13(2):e13047. doi: 10.7759/cureus.13047. PMID: 33643746; PMCID: PMC7885746.

Potential risk for developing severe COVID-19 disease among anabolic steroid users. Cadegiani F, Lin EM, Goren A, Wambier CG. BMJ Case Rep. 2021 Feb 26;14(2):e241572. doi: 10.1136/bcr-2021-241572. PMID: 33637513; PMCID: PMC7919571.

Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial. Cadegiani FA, McCoy J, Gustavo Wambier C, Vaño-Galván S, Shapiro J, Tosti A, Zimerman RA, Goren A. Cureus. 2021 Feb 22;13(2):e13492. doi: 10.7759/cureus.13492. PMID: 33633920; PMCID: PMC7899267.

The AndroCoV Clinical Scoring for COVID-19 Diagnosis: A Prompt, Feasible, Costless, and Highly Sensitive Diagnostic Tool for COVID-19 Based on a 1757-Patient Cohort. Cadegiani FA, Zimerman RA, Campello de Souza B, McCoy J, Pereira E Costa RA, Gustavo Wambier C, Goren A. Cureus. 2021 Jan 7;13(1):e12565. doi: 10.7759/cureus.12565. PMID: 33437562; PMCID: PMC7793341.

Scalp neuropathy in androgenetic alopecia. Cavanagh G, Goren A, Wambier CG. J Am Acad Dermatol. 2022 Jan;86(1):183-184. doi: 10.1016/j.jaad.2021.01.034. Epub 2021 Jan 19. PMID: 33476730.

Spironolactone in adolescent acne vulgaris. Dhurat R, Shukla D, Lim RK, Wambier CG, Goren A. Dermatol Ther. 2021 Jan;34(1):e14680. doi: 10.1111/dth.14680. Epub 2020 Dec 21. PMID: 33326148.

Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster. Goren A, Cadegiani FA, Wambier CG, Vano-Galvan S, Tosti A, Shapiro J, Mesinkovska NA, Ramos PM, Sinclair R, Lupi O, Hercogova J, McCoy J. Med Hypotheses. 2021
Jan;146:110439. doi: 10.1016/j.mehy.2020.110439. Epub 2020 Nov 28. PMID: 33308937; PMCID: PMC7695567.

Reply to comment on: The Gabrin sign. Wambier CG, Vaño-Galván S, Goren A. J Am Acad Dermatol. 2021 Mar;84(3):e149-e150. doi: 10.1016/j.jaad.2020.11.045. Epub 2020 Nov 27. PMID: 33253847; PMCID: PMC7834497.

5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia. McCoy J, Cadegiani FA, Wambier CG, Herrera S, Vaño-Galván S, Mesinkovska NA, Ramos PM, Shapiro J, Sinclair R, Tosti A, Goren A. J Eur Acad Dermatol Venereol. 2021 Apr;35(4):e243-e246. doi: 10.1111/jdv.17021. Epub 2020 Nov 22. Erratum in: J Eur Acad Dermatol Venereol. 2021 Jul;35(7):1595. PMID: 33135263.

Clinical symptoms of hyperandrogenic women diagnosed with COVID-19. Cadegiani FA, Lim RK, Goren A, McCoy J, Situm M, Kovacevic M, Vañó Galván S, Sinclair R, Tosti A, Wambier CG. J Eur Acad Dermatol Venereol. 2021 Feb;35(2):e101-e104. doi: 10.1111/jdv.17004. Epub 2020 Nov 8. Erratum in: J Eur Acad Dermatol Venereol. 2021 Jul;35(7):1595. PMID: 33089570.

Letter to the Editor: Environmental Effects on Reported Infections and Death Rates of COVID-19 Across 91 Major Brazilian Cities. Lin EM, Goren A, Wambier C. High Alt Med Biol. 2020 Dec;21(4):431-433. doi: 10.1089/ham.2020.0168. Epub 2020 Oct 8. PMID: 33031012.

Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men. Goren A, Wambier CG, Herrera S, McCoy J, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Ramos PM, Cadegiani FA, Kovacevic M, Tosti A, Shapiro J, Sinclair R. J Eur Acad Dermatol Venereol. 2021 Jan;35(1):e13-e15. doi: 10.1111/jdv.16953. Epub 2020 Oct 21. Erratum in: J Eur Acad Dermatol Venereol. 2021 Jul;35(7):1595. PMID:
32977363; PMCID: PMC7536996.

Androgen receptor genetic variant predicts COVID-19 disease severity: a prospective longitudinal study of hospitalized COVID-19 male patients. McCoy J, Wambier CG, Herrera S, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Iwasiow RM, Tayeb MA, Cadegiani FA, Mesinkovska NA, Shapiro J, Sinclair R, Goren A. J Eur Acad Dermatol Venereol. 2021 Jan;35(1):e15-e17. doi: 10.1111/jdv.16956. Epub 2020 Oct 21. Erratum in: J Eur Acad Dermatol Venereol. 2021 Jul;35(7):1595. PMID: 32977355; PMCID: PMC7536899.

Novel cannabidiol sunscreen protects keratinocytes and melanocytes against ultraviolet B radiation. Gohad P, McCoy J, Wambier C, Kovacevic M, Situm M, Stanimirovic A, Goren A. J Cosmet Dermatol. 2020 Sep 16. doi: 10.1111/jocd.13693. Epub ahead of print. PMID: 32964699.

Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals. Wambier CG, McCoy J, Goren A. J Am Acad Dermatol. 2020 Dec;83(6):e401-e402. doi: 10.1016/j.jaad.2020.09.015. Epub 2020 Sep 11. PMID:
32926978; PMCID: PMC7484621.

Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19. Cadegiani FA, Wambier CG, Goren A. Front Med (Lausanne). 2020 Jul 28;7:453. doi: 10.3389/fmed.2020.00453. PMID: 32850920; PMCID: PMC7399048.

Novel “After Minoxidil” spray improves topical minoxidil compliance and hair style manageability. Kovacevic M, McCoy J, Shapiro J, Sinclair R, Vaño-Galvan S, Goldust M, Situm M, Goren A. J Cosmet Dermatol. 2020 Oct;19(10):2647-2649. doi: 10.1111/jocd.13630. Epub 2020 Aug 26. PMID: 32844529.

Androgen sensitivity in COVID-19 and antiandrogens: Prospective data are still needed. Ianhez M, Ramos PM, Goren A, Miot HA. Dermatol Ther. 2020 Nov;33(6):e14166. doi: 10.1111/dth.14166. Epub 2020 Sep 3. PMID: 32772478; PMCID: PMC7435489.

Are night shift workers at an increased risk for COVID-19? Lim RK, Wambier CG, Goren A. Med Hypotheses. 2020 Nov;144:110147. doi: 10.1016/j.mehy.2020.110147. Epub 2020 Jul 29. PMID: 32758906; PMCID: PMC7387356.

Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign. Wambier CG, Vaño-Galván S, McCoy J, Pai S, Dhurat R, Goren A. J Am Acad Dermatol. 2020 Dec;83(6):e453-e454. doi: 10.1016/j.jaad.2020.07.099. Epub 2020 Jul 29. PMID: 32735970; PMCID: PMC7387285.

Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS). Cadegiani FA, Goren A, Wambier CG. Med Hypotheses. 2020 Oct;143:110112. doi: 10.1016/j.mehy.2020.110112. Epub 2020 Jul 16. PMID: 32721806; PMCID: PMC7363620.

Clock genes may drive seasonal variation in SARS-CoV-2 infectivity: are we due for a second wave of COVID-19 in the fall? Goren A, Wambier CG, McCoy J, Shapiro J, Vaño-Galván S, Herrera S, Glode LM. J Biol Regul Homeost Agents. 2020 Jul-Aug,;34(4):1455-1457. doi: 10.23812/20-359-L-35. PMID: 32700513.

Minoxidil Sulfotransferase Enzyme (SULT1A1) genetic variants predicts response to oral minoxidil treatment for female pattern hair loss. Ramos PM, Gohad P, McCoy J, Wambier C, Goren A. J Eur Acad Dermatol Venereol. 2021 Jan;35(1):e24-e26. doi: 10.1111/jdv.16765. Epub 2020 Jul 9. PMID: 32567076.

Safety measures in dermatology help minimize spread of COVID-19. Goren A, Rathod D, Kroumpouzos G, Jafferany M, Goldust M. Dermatol Ther. 2020 Jul;33(4):e13773. doi: 10.1111/dth.13773. Epub 2020 Jul 7. PMID: 32506600; PMCID: PMC7300612.

Microneedling improves minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes. Sharma A, Surve R, Dhurat R, Sinclair R, Tan T, Zou Y, Müller Ramos P, Wambier C, Verner I, Kovacevic M, Goren A. J Biol Regul Homeost Agents. 2020 Mar-Apr;34(2):659-661. doi: 10.23812/19-385-L-51. PMID: 32492993.

Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”. Wambier CG, Vaño-Galván S, McCoy J, Gomez-Zubiaur A, Herrera S, Hermosa-Gelbard Á, Moreno-Arrones OM, Jiménez-Gómez N, González-Cantero A, Fonda-Pascual P, Segurado-Miravalles G, Shapiro J, Pérez-García B, Goren A. J Am Acad Dermatol. 2020 Aug;83(2):680-682. doi: 10.1016/j.jaad.2020.05.079. Epub 2020 May 22. PMID: 32446821; PMCID: PMC7242206.

Novel topical booster enhances follicular sulfotransferase activity in patients with androgenetic alopecia: a new strategy to improve minoxidil response. Ramos PM, McCoy J, Wambier C, Shapiro J, Vañó-Galvan S, Sinclair R, Goren A. J Eur Acad Dermatol Venereol. 2020 Dec;34(12):e799-e800. doi: 10.1111/jdv.16645. Epub 2020 Jun 10. PMID: 32432358.

Androgen sensitivity gateway to COVID-19 disease severity. Wambier CG, Goren A, Vaño-Galván S, Ramos PM, Ossimetha A, Nau G, Herrera S, McCoy J. Drug Dev Res. 2020 Nov;81(7):771-776. doi: 10.1002/ddr.21688. Epub 2020 May 15. PMID: 32412125; PMCID: PMC7273095.

Topical Alpha-1 Adrenergic Receptor Agonist Applied to the Nipple/Areola Complex Improves Female Orgasmic Function. Goren A, McCoy J, Krychman M, Brandt L, Lah A, Lonky N. J Womens Health (Larchmt). 2020 Jul;29(7):1017-1020. doi: 10.1089/jwh.2019.8188. Epub 2020 May 12. PMID: 32397852.

Allergic contact dermatitis in patients with frontal fibrosing alopecia: An international multi-center study. Rudnicka L, Rokni GR, Lotti T, Wollina U, Fölster-Holst R, Katsambas A, Goren A, Di Lernia VG, Rathod D, Mirabi A, Ghaffari A, Rajan A, Goldust M. Dermatol Ther. 2020 Jul;33(4):e13560. doi: 10.1111/dth.13560. Epub 2020 Jun 4. PMID: 32396259.

Novel yeast extract is superior to colloidal oatmeal in providing rapid itch relief. Dhurat R, Sharma A, Surve R, McCoy J, Kovacevic M, Goren A, Tan Y, Zou Y, Goldust M, Situm M, Stanimirovic A. J Cosmet Dermatol. 2021 Jan;20(1):207-209. doi: 10.1111/jocd.13436. Epub 2020 May 2. PMID: 32359021.

Racial variations in COVID-19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti-androgens a potential treatment for COVID-19? McCoy J, Wambier CG, Vano-Galvan S, Shapiro J, Sinclair R, Ramos PM, Washenik K, Andrade M, Herrera S, Goren A. J Cosmet Dermatol. 2020 Jul;19(7):1542-1543. doi: 10.1111/jocd.13455. Epub 2020 Jun 14. PMID: 32333494; PMCID: PMC7267367.

A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain – A potential clue to the role of androgens in COVID-19 severity. Goren A, Vaño-Galván S, Wambier CG, McCoy J, Gomez-Zubiaur A, Moreno-Arrones OM, Shapiro J, Sinclair RD, Gold MH, Kovacevic M, Mesinkovska NA, Goldust M, Washenik K. J Cosmet Dermatol. 2020 Jul;19(7):1545-1547. doi: 10.1111/jocd.13443. Epub 2020 Apr 23. PMID: 32301221.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated. Wambier CG, Goren A. J Am Acad Dermatol. 2020 Jul;83(1):308-309. doi: 10.1016/j.jaad.2020.04.032. Epub 2020 Apr 10. PMID: 32283245; PMCID: PMC7151476.

What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy. Goren A, McCoy J, Wambier CG, Vano-Galvan S, Shapiro J, Dhurat R, Washenik K, Lotti T. Dermatol Ther. 2020 Jul;33(4):e13365. doi: 10.1111/dth.13365. Epub 2020 Apr 8. PMID: 32237190; PMCID: PMC7228378.

STAT3-mutated hyperimmunoglobulin E syndrome with perianal skin tags and erosions: A case report. Fölster-Holst R, Kazeminejad A, Rokni GR, Lotti T, Goren A, Goldust M. Dermatol Ther. 2020 May;33(3):e13333. doi: 10.1111/dth.13333. Epub 2020 Apr 3. PMID: 32219963.

Low-level laser therapy and narrative review of other treatment modalities in androgenetic alopecia. Galadari H, Shivakumar S, Lotti T, Wollina U, Goren A, Rokni GR, Grabbe S, Goldust M. Lasers Med Sci. 2020 Aug;35(6):1239-1244. doi: 10.1007/s10103-020-02994-4. Epub 2020 Mar 11. PMID: 32162134.

Erosive pustular dermatosis of the scalp: a multicentre study. Starace M, Iorizzo M, Trüeb RM, Piccolo V, Argenziano G, Camacho FM, Gallyamova Y, Rudnicka L, Umbert I, Lyakhovitsky A, Vañó-Galván S, Goren A, Alessandrini A, Bruni F, Piraccini BM. J Eur Acad Dermatol Venereol. 2020 Jun;34(6):1348-1354. doi: 10.1111/jdv.16211. Epub 2020 Feb 9. PMID: 31954062.

Yeast extract demonstrates rapid itch relief in chronic pruritus. Zhang Y, Tan Y, Zou Y, Bulat V, Lugovic Mihic L, Kovacevic M, Lotti T, Verner I, Stanimirovic A, Situm M, Goldust M, Liu W, Vojvodic A, Goren A. J Cosmet Dermatol. 2020 Aug;19(8):2131-2134. doi: 10.1111/jocd.13265. Epub 2020 Jan 10. PMID: 31922345.

Non-ablative radio frequency for the treatment of androgenetic alopecia. Tan Y, Wei L, Zhang Y, Goren A, McCoy J, Stanimirovic A, Lotti T, KovacevicM. Acta Dermatovenerol Alp Pannonica Adriat. 2019 Dec;28(4):169-171. PMID: 31855270.

Can we halt male androgenetic alopecia progression without antiandrogenic drugs? Ramos PM, Santos LDN, Mesinkovska NA, Goren A, Miot HA. Dermatol Ther. 2020 Jan;33(1):e13197. doi: 10.1111/dth.13197. Epub 2020 Jan 2. PMID: 31846191.

Novel topical formulation applied to the nipple-areola complex improves female orgasm. Krychman M, Goren A, Brandt L, McCoy J. J Cosmet Dermatol. 2020 Feb;19(2):404-406. doi: 10.1111/jocd.13262. Epub 2019 Dec 17. PMID: 31846189.

Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil treatment in Brazilian female pattern hair loss patients. Ramos PM, Sinclair R, Miot HA, Goren A. Dermatol Ther. 2020 Jan;33(1):e13195. doi: 10.1111/dth.13195. Epub 2019 Dec 27. PMID: 31846181.

Efficacy of topical latanoprost in the treatment of eyelid vitiligo: A randomized, double-blind clinical trial study. Nowroozpoor Dailami K, Hosseini A, Rahmatpour Rokni G, Saeedi M, Morteza-Semnani K, Sadeghi Z, Ghasemzadeh Diva SM, Goldust M, Lotti T, Vojvodic A, Goren A, Sonthalia S, Rathod D. Dermatol Ther. 2020 Jan;33(1):e13175. doi: 10.1111/dth.13175. Epub 2019 Dec 26. PMID: 31758835.

Vemurafenib and cobimetinib-induced toxic epidermal necrolysis in a patient with metastatic melanoma. Poduje S, Brozić JM, Prkačin I, Delaš Aždajić M, Goren A. Dermatol Ther. 2020 Jan;33(1):e13174. doi: 10.1111/dth.13174. Epub 2019 Dec 11. PMID: 31750971.

Oral minoxidil bio-activation by hair follicle outer root sheath cell sulfotransferase enzymes predicts clinical efficacy in female pattern hair loss. Ramos PM, Goren A, Sinclair R, Miot HA. J Eur Acad Dermatol Venereol. 2020 Jan;34(1):e40-e41. doi: 10.1111/jdv.15891. Epub 2019 Sep 11. PMID: 31420889.

Novel shampoo reduces hair shedding by contracting the arrector pili muscle via the trace amine-associated receptor. Kovacevic M, McCoy J, Goren A, Situm M, Stanimirovic A, Liu W, Tan Y, Vaño-Galvan S, Shapiro J, Sinclair R. J Cosmet Dermatol. 2019 Dec;18(6):2037-2039. doi: 10.1111/jocd.13054. Epub 2019 Jul 2. PMID: 31264766.

Identification of the sulfotransferase iso-enzyme primarily responsible for the bio-activation of topical minoxidil. McCoy J, Goren A, Naccarato T, Kovacevic M, Situm M, Skudar VL, Lotti T. J Biol Regul Homeost Agents. 2019 May-Jun,;33(3):817-819. PMID: 31184104.

Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes. Sharma A, Goren A, Dhurat R, Agrawal S, Sinclair R, Trüeb RM, Vañó-Galván S, Chen G, Tan Y, Kovacevic M, Situm M, McCoy J. Dermatol Ther. 2019 May;32(3):e12915. doi: 10.1111/dth.12915. Epub 2019 Apr 23. PMID: 30974011.

Evaluation of the glycemic effect of methotrexate in psoriatic arthritis patients with metabolic syndrome: A pilot study. Dehpouri T, Rokni GR, Narenjbon NA, Goldust M, Yamauchi PS, Wollina U, Lotti T, Kircik L, Lernia VGD, Sonthalia S, Vojvodic A, Szepietowski J, Bahadoran P, Errichetti E, Cantisani C, Atzori L, Rezaee E, Kutlubay Z, Engin B, Nisticò S, Damiani G, Conic RRZ, Goren A, Čabrijan L, Tchernev G. Dermatol Reports. 2019 May 9;11(1):7965. doi: 10.4081/dr.2019.7965. PMID: 31210916; PMCID: PMC6547029.

Mission impossible: Dermal delivery of growth factors via microneedling. Dhurat R, Sharma A, Goren A, Daruwalla S, Situm M, Kovacevic M. Dermatol Ther. 2019 May;32(3):e12897. doi: 10.1111/dth.12897. Epub 2019 Apr 22. PMID: 30963686.

Platelet rich plasma in androgenetic alopecia: A systematic review. Lotti T, Goren A, Verner I, D’Alessio PA, Franca K. Dermatol Ther. 2019 May;32(3):e12837. doi: 10.1111/dth.12837. Epub 2019 Mar 26. PMID: 30667146.

Frontal pattern hair loss among Chinese women is frequently associated with ponytail hairstyle. Goren A, Wei L, Tan Y, Kovacevic M, McCoy J, Lotti T. Dermatol Ther. 2019 Jan;32(1):e12784. doi: 10.1111/dth.12784. Epub 2018 Dec 6. PMID: 30458063.

Characterization of follicular minoxidil sulfotransferase activity in a cohort of pattern hair loss patients from the Indian Subcontinent. Chitalia J, Dhurat R, Goren A, McCoy J, Kovacevic M, Situm M, Naccarato T, Lotti T. Dermatol Ther. 2018 Nov;31(6):e12688. doi: 10.1111/dth.12688. Epub 2018 Oct 8. PMID: 30295395.

Anterior, frontal congenital triangular alopecia, redundancy in therapy without improvement. Goldust M, Rahmatpour Rokni G, Sadr S, Mirabi A, Rezaee E, Goren A, Lotti T. Dermatol Ther. 2018 Nov;31(6):e12698. doi: 10.1111/dth.12698. Epub 2018 Oct 3. PMID: 30284356.

Low-dose daily aspirin reduces topical minoxidil efficacy in androgenetic alopecia patients. Goren A, Sharma A, Dhurat R, Shapiro J, Sinclair R, Situm M, Kovacevic M, Lukinovic Skudar V, Goldust M, Lotti T, McCoy J. Dermatol Ther. 2018 Nov;31(6):e12741. doi: 10.1111/dth.12741. Epub 2018 Oct 8. PMID: 30226287.

Minoxidil in the treatment of androgenetic alopecia.Goren A, Naccarato T.  Dermatol Ther. 2018 Sep;31(5):e12686. doi: 10.1111/dth.12686. Epub 2018 Aug 28. PMID: 30155952.

The effect of topical minoxidil treatment on follicular sulfotransferase enzymatic activity. Goren A, Mccoy J, Kovacevic M, Situm M, Chitalia J, Dhurat R, Naccarato T, Lotti T. J Biol Regul Homeost Agents. 2018 Jul-Aug;32(4):937-940. PMID: 30043580.

Micro-Focused Phototherapy Associated To Janus Kinase Inhibitor: A Promising Valid Therapeutic Option for Patients with Localized Vitiligo. Gianfaldoni S, Tchernev G, Wollina U, Roccia MG, Fioranelli M, Lotti J, Rovesti M, Satolli F, Valle Y, Goren A, Tirant M, Situm M, Kovacevic M, França K, Lotti T. Open Access Maced J Med Sci. 2018 Jan 21;6(1):46-48. doi: 10.3889/oamjms.2018.042. PMID: 29483979; PMCID: PMC5816312.

Mechanism of action of minoxidil in the treatment of androgenetic alopecia is likely mediated by mitochondrial adenosine triphosphate synthase-induced stem cell differentiation. Goren A, Naccarato T, Situm M, Kovacevic M, Lotti T, McCoy J. J Biol Regul Homeost Agents. 2017 Oct-Dec;31(4):1049-1053. PMID: 29254313.

Social selection favours offspring prone to the development of androgenetic alopecia. Goren A, Shapiro J, Naccarato T, Situm M, Kovacevic M, Lonky N, Lotti T, McCoy J. J Biol Regul Homeost Agents. 2017 Oct-Dec;31(4):1013-1016. PMID: 29254307.

Novel topical formula reduces hair shedding by contracting the arrector pili muscle. McCoy J, Goren A, Kovacevic M, Situm M, Stanimirovic A, Shapiro J, Sinclair R. Styling without shedding: Dermatol Ther. 2018 Jan;31(1). doi: 10.1111/dth.12575. Epub 2017 Nov 28. PMID: 29193553.

Potential risk of developing herpes simplex encephalitis in patients treated with sildenafil following primary exposure to genital herpes.Goren A, McCoy J, Kovacevic M, Situm M, Lonky N.  J Biol Regul Homeost Agents. 2017 Jul-Sep;31(3):679-682. PMID: 28956417.

Melanin of the nipple areola complex. Goren A, Kovacevic M, Lotti T. J Biol Regul Homeost Agents. 2017 Jan-Mar;31(1):237-238. PMID: 28337898.

Minoxidil dose response study in female pattern hair loss patients determined to be non-responders to 5% topical minoxidil. McCoy J, Goren A, Kovacevic M, Shapiro J. J Biol Regul Homeost Agents. 2016 Oct-Dec;30(4):1153-1155. PMID: 28078868.

Genital psoriasis: a hidden multidisciplinary problem – a review of literature. Czuczwar P, Stępniak A, Goren A, Wrona W, Paszkowski T, Pawlaczyk M, Piekarska-Myślińska D, Woźniak S, Pietrzak A. Ginekol Pol. 2016;87(10):717-721. doi: 10.5603/GP.2016.0074. PMID: 27958625.

Novel technique for repigmentation of senescence grey hair. Goren A, Bolanča Ž, Lotti T, Šitum M. Dermatol Ther. 2017 Mar;30(2). doi: 10.1111/dth.12436. Epub 2016 Dec 5. PMID: 27917579.

Prevalence of hair shedding among women. Kovacevic M, Goren A, Shapiro J, Sinclair R, Lonky NM, Situm M, Bulat V, Bolanca Z, McCoy J. Dermatol Ther. 2017 Jan;30(1):e12415. doi: 10.1111/dth.12415. Epub 2016 Oct 6. PMID: 27712018; PMCID: PMC6175177.

Doppler laser imaging predicts response to topical minoxidil in the treatment of female pattern hair loss. McCoy J, Kovacevic M, Situm M, Stanimirovic A, Bolanca Z, Goren A. J Biol Regul Homeost Agents. 2016 Jan-Mar;30(1):131-4. PMID: 27049083.

Platelet-rich plasma as a novel treatment for lichen planopillaris. Bolanča Ž, Goren A, Getaldić-Švarc B, Vučić M, Šitum M. Dermatol Ther. 2016 Jul;29(4):233-5. doi: 10.1111/dth.12343. Epub 2016 Mar 14. PMID: 26988129.

Mixed vitiligo of Blaschko lines: a newly discovered presentation of vitiligo responsive to combination treatment. Kovacevic M, Stanimirovic A, Vucic M, Goren A, Situm M, Lukinovic Skudar V, Lotti T. Dermatol Ther. 2016 Jul;29(4):240-3. doi: 10.1111/dth.12345. Epub 2016 Mar 11. PMID: 26970077.

Management of chronic pruritus with a UV filtering topical cream. Zanardelli M, Kovacevic M, McCoy J, Wang X, Goren A, Lotti T. Dermatol Ther. 2016 Mar-Apr;29(2):101-3. doi: 10.1111/dth.12309. Epub 2015 Nov 2. PMID: 26849280.

Melanocytes precursor cells as a novel treatment for vitiligo. Zanardelli M, Goren A, Lotti T. G Ital Dermatol Venereol. 2016 Dec;151(6):726-727. Epub 2015 Dec 23. PMID: 26698273.

α1 -AR agonist induced piloerection protects against the development of traction alopecia. Goren A, Shapiro J, Sinclair R, Kovacevic M, McCoy J. Dermatol Ther. 2016 May;29(3):160-3. doi: 10.1111/dth.12324. Epub 2015 Dec 17. PMID: 26678522.

Topical cream delivers NB-UVB from sunlight for the treatment of vitiligo. Wang X, McCoy J, Lotti T, Goren A. Expert Opin Pharmacother. 2014 Dec;15(18):2623-7. doi: 10.1517/14656566.2014.978287. Epub 2014 Nov 3. PMID: 25363734.

Clinical utility and validity of minoxidil response testing in androgenetic alopecia. Goren A, Shapiro J, Roberts J, McCoy J, Desai N, Zarrab Z, Pietrzak A, Lotti T. Dermatol Ther. 2015 Jan-Feb;28(1):13-6. doi: 10.1111/dth.12164. Epub 2014 Aug 12. PMID: 25112173.

Acute telogen effluvium onset event is associated with the presence of female androgenetic alopecia: potential therapeutic implications. Perez-Mora N, Goren A, Velasco C, Bermudez F. Dermatol Ther. 2014 May-Jun;27(3):159-62. doi: 10.1111/dth.12101. PMID: 24850277.

Novel topical cream delivers safe and effective alternative to traditional psoriasis phototherapy. Goren A, Salafia A, McCoy J, Keene S, Lotti T, Petrusevska A. Dermatol Ther. 2014 Sep-Oct;27(5):260-3. doi: 10.1111/dth.12132. Epub 2014 Apr 28. PMID: 24773915.

Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia. Roberts J, Desai N, McCoy J, Goren A. Dermatol Ther. 2014 Jul-Aug;27(4):252-4. doi: 10.1111/dth.12130. Epub 2014 Apr 28. PMID: 24773771.

Novel topical cream delivers safe and effective sunlight therapy for vitiligo by selectively filtering damaging ultraviolet radiation. Goren A, Salafia A, McCoy J, Keene S, Lotti T. Dermatol Ther. 2014 Jul-Aug;27(4):195-7. doi: 10.1111/dth.12115. Epub 2014 Feb 18. PMID: 24548413.

Novel enzymatic assay predicts minoxidil response in the treatment of androgenetic alopecia. Goren A, Castano JA, McCoy J, Bermudez F, Lotti T. Dermatol Ther. 2014 May-Jun;27(3):171-3. doi: 10.1111/dth.12111. Epub 2013 Nov 27. PMID: 24283387.

In vitro evaluation of a novel topical cream for vitiligo and psoriasis that selectively delivers NB-UVB therapy when exposed to sunlight. McCoy J, Goren A, Lotti T. Dermatol Ther. 2014 Mar-Apr;27(2):117-20. doi: 10.1111/dth.12079. Epub 2013 Jul 16. PMID: 23952638.

Therapeutic hotline. Genetic variations in the androgen receptor gene and finasteride response in women with androgenetic alopecia mediated by epigenetics. Keene S, Goren A. Dermatol Ther. 2011 Mar-Apr;24(2):296-300. doi: 10.1111/j.1529-8019.2011.01407.x. PMID: 21410621.